SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001367644-10-000008
Filing Date
2010-03-05
Accepted
2010-03-05 15:22:46
Documents
17
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2372861
2 ex10_6.htm EX-10.6 30869
3 ex10_7.htm EX-10.7 5687
4 ex10_18.htm EX-10.18 32310
5 ex10_19.htm EX-10.19 15106
6 ex10_20.htm EX-10.20 16947
7 ex10_21.htm EX-10.21 19624
8 ex10_22.htm EX-10.22 84868
9 ex10_26.htm EX-10.26 73406
10 ex10_40.htm EX-10.40 184131
11 ex10_41.htm EX-10.41 35195
12 ex21_1.htm EX-21.1 12945
13 ex23_1.htm EX-23.1 6421
14 ex31_1.htm EX-31.1 16713
15 ex31_2.htm EX-31.2 17059
16 ex32_1.htm EX-32.1 6917
17 ex32_2.htm EX-32.2 6918
  Complete submission text file 0001367644-10-000008.txt   2939389
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 10660471
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences